Exploring the potential role of glucose metabolism in migraine: A cross-sectional study from a tertiary care hospital
Abstract
Background: Migraine is a complex neurovascular disorder of the brain. Impaired glucose metabolism is suspected to have a potential role in the pathogenesis of migraine.
Aims and Objectives: This study aimed to evaluate the association between fasting glucose, fasting insulin, and type 2 diabetes with migraine.
Materials and Methods: A cross-sectional study was conducted involving 29 female patients diagnosed with migraine based on the international classification of headache disorders 3 criteria. Participants underwent physical examinations to assess obesity and metabolic syndrome. Serum insulin, homeostatic model assessment of insulin resistance (HOMA-IR), fasting blood glucose (FBG), and lipid profiles were measured.
Results: The mean FBG (97.36±31.7) and total cholesterol (162.96±39.13), triglyceride, (112.5±49.51), low-density lipoprotein (99.43–28.90), and high-density lipoprotein (48.75±7.58) values were within normal limits. HOMA-IR was marginally elevated (mean 2.56±1.69; 95% conflict interval: 1.9–3.22), indicating insulin resistance (IR). A statistically significant difference in FBG was observed between patients with and without IR (median FBG: 90; U=29; z=−3.32; P=0.001) but no significant differences were found in body mass index or lipid profile (P>0.05).
Conclusion: Impaired glucose metabolism was found to have an impact on migraine pathophysiology.
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 29 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.